Full Press Release Details
Tori brings deep experience in helping to build biotech companies and brands, with over two decades working across the industry.
Most recently, Tori played an instrumental role in transitioning Frontier Medicines into a clinical-stage organization. As a key member of the leadership team and SVP, Strategy and Corporate Affairs, she led investor relations and corporate strategy, guiding the company through an oversubscribed Series C financing round.
Prior to joining Frontier, Tori founded and led uncapped, a leading biotech consultancy, as part of the GCI Health Group and WPP Companies. During her tenure, uncapped and GCI Health Group experienced rapid growth, helping to guide emerging and leading companies including Nkarta, Apellis, Dynavax, Exscientia and many others. Prior to founding Frontier, Tori served as an Executive Vice President at GCI Health, working with large biopharmaceutical companies on a global scale.
Tori has helped to launch and grow some of the world’s leading precision medicines. Her team’s efforts have garnered numerous industry recognitions and she received MM&M’s inaugural 40 Under 40 award. Tori received a bachelor’s degree in economics from Smith College.